Orthofix Medical Competitors

Orthofix Medical (NASDAQ:OFIX) and Abbott Laboratories (NYSE:ABT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

Earnings & Valuation

This table compares Orthofix Medical and Abbott Laboratories' revenue, earnings per share and valuation.

Abbott Laboratories has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Orthofix Medical and Abbott Laboratories, as reported by MarketBeat.

Orthofix Medical presently has a consensus target price of $45.6667, suggesting a potential upside of 22.96%. Abbott Laboratories has a consensus target price of $115.3750, suggesting a potential upside of 5.59%. Given Orthofix Medical's higher probable upside, equities analysts clearly believe Orthofix Medical is more favorable than Abbott Laboratories.

Volatility and Risk

Orthofix Medical has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500.

Profitability

This table compares Orthofix Medical and Abbott Laboratories' net margins, return on equity and return on assets.

Institutional & Insider Ownership

93.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 63.9% of Abbott Laboratories shares are held by institutional investors. 3.5% of Orthofix Medical shares are held by insiders. Comparatively, 1.7% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Abbott Laboratories beats Orthofix Medical on 10 of the 14 factors compared between the two stocks.

Medtronic (NYSE:MDT) and Orthofix Medical (NASDAQ:OFIX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Earnings and Valuation

This table compares Medtronic and Orthofix Medical's top-line revenue, earnings per share and valuation.

Medtronic has higher revenue and earnings than Orthofix Medical. Medtronic is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for Medtronic and Orthofix Medical, as provided by MarketBeat.com.

Medtronic presently has a consensus price target of $118.1538, suggesting a potential upside of 6.47%. Orthofix Medical has a consensus price target of $45.6667, suggesting a potential upside of 22.96%. Given Orthofix Medical's higher probable upside, analysts plainly believe Orthofix Medical is more favorable than Medtronic.

Volatility & Risk

Medtronic has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.

Profitability

This table compares Medtronic and Orthofix Medical's net margins, return on equity and return on assets.

Institutional & Insider Ownership

79.9% of Medtronic shares are held by institutional investors. Comparatively, 93.8% of Orthofix Medical shares are held by institutional investors. 0.5% of Medtronic shares are held by company insiders. Comparatively, 3.5% of Orthofix Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Medtronic beats Orthofix Medical on 11 of the 15 factors compared between the two stocks.

Stryker (NYSE:SYK) and Orthofix Medical (NASDAQ:OFIX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Earnings and Valuation

This table compares Stryker and Orthofix Medical's top-line revenue, earnings per share and valuation.

Stryker has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for Stryker and Orthofix Medical, as provided by MarketBeat.com.

Stryker presently has a consensus price target of $221.44, suggesting a potential downside of 4.97%. Orthofix Medical has a consensus price target of $45.6667, suggesting a potential upside of 22.96%. Given Orthofix Medical's higher probable upside, analysts plainly believe Orthofix Medical is more favorable than Stryker.

Volatility & Risk

Stryker has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.

Profitability

This table compares Stryker and Orthofix Medical's net margins, return on equity and return on assets.

Institutional & Insider Ownership

71.0% of Stryker shares are held by institutional investors. Comparatively, 93.8% of Orthofix Medical shares are held by institutional investors. 6.8% of Stryker shares are held by company insiders. Comparatively, 3.5% of Orthofix Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Stryker beats Orthofix Medical on 12 of the 15 factors compared between the two stocks.

Intuitive Surgical (NASDAQ:ISRG) and Orthofix Medical (NASDAQ:OFIX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Volatility & Risk

Intuitive Surgical has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.

Earnings and Valuation

This table compares Intuitive Surgical and Orthofix Medical's top-line revenue, earnings per share and valuation.

Intuitive Surgical has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for Intuitive Surgical and Orthofix Medical, as provided by MarketBeat.com.

Intuitive Surgical presently has a consensus price target of $718.2778, suggesting a potential downside of 0.11%. Orthofix Medical has a consensus price target of $45.6667, suggesting a potential upside of 22.96%. Given Orthofix Medical's higher probable upside, analysts plainly believe Orthofix Medical is more favorable than Intuitive Surgical.

Profitability

This table compares Intuitive Surgical and Orthofix Medical's net margins, return on equity and return on assets.

Institutional & Insider Ownership

86.9% of Intuitive Surgical shares are held by institutional investors. Comparatively, 93.8% of Orthofix Medical shares are held by institutional investors. 1.6% of Intuitive Surgical shares are held by company insiders. Comparatively, 3.5% of Orthofix Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Intuitive Surgical beats Orthofix Medical on 10 of the 14 factors compared between the two stocks.

Becton, Dickinson and (NYSE:BDX) and Orthofix Medical (NASDAQ:OFIX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Risk and Volatility

Becton, Dickinson and has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500.

Earnings & Valuation

This table compares Becton, Dickinson and and Orthofix Medical's top-line revenue, earnings per share and valuation.

Becton, Dickinson and has higher revenue and earnings than Orthofix Medical. Becton, Dickinson and is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings for Becton, Dickinson and and Orthofix Medical, as provided by MarketBeat.

Becton, Dickinson and presently has a consensus price target of $280.2857, suggesting a potential upside of 22.67%. Orthofix Medical has a consensus price target of $45.6667, suggesting a potential upside of 22.96%. Given Orthofix Medical's higher probable upside, analysts clearly believe Orthofix Medical is more favorable than Becton, Dickinson and.

Profitability

This table compares Becton, Dickinson and and Orthofix Medical's net margins, return on equity and return on assets.

Institutional and Insider Ownership

74.4% of Becton, Dickinson and shares are held by institutional investors. Comparatively, 93.8% of Orthofix Medical shares are held by institutional investors. 0.1% of Becton, Dickinson and shares are held by insiders. Comparatively, 3.5% of Orthofix Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Becton, Dickinson and beats Orthofix Medical on 11 of the 15 factors compared between the two stocks.

Edwards Lifesciences (NYSE:EW) and Orthofix Medical (NASDAQ:OFIX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Risk and Volatility

Edwards Lifesciences has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500.

Earnings & Valuation

This table compares Edwards Lifesciences and Orthofix Medical's top-line revenue, earnings per share and valuation.

Edwards Lifesciences has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings for Edwards Lifesciences and Orthofix Medical, as provided by MarketBeat.

Edwards Lifesciences presently has a consensus price target of $87.7222, suggesting a potential upside of 3.57%. Orthofix Medical has a consensus price target of $45.6667, suggesting a potential upside of 22.96%. Given Orthofix Medical's higher probable upside, analysts clearly believe Orthofix Medical is more favorable than Edwards Lifesciences.

Profitability

This table compares Edwards Lifesciences and Orthofix Medical's net margins, return on equity and return on assets.

Institutional and Insider Ownership

79.7% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 93.8% of Orthofix Medical shares are held by institutional investors. 1.5% of Edwards Lifesciences shares are held by insiders. Comparatively, 3.5% of Orthofix Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Edwards Lifesciences beats Orthofix Medical on 10 of the 14 factors compared between the two stocks.